Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

pembrolizumab 245Nivolumab 141Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 78atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 48Standard of Care 45Magnetic Resonance Spectroscopy 45Capecitabine 45Radiosurgery 44Cetuximab 44lenvatinib 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Flow Cytometry × 1 year × Clear all
NCT05622682 2026-01-26

VIRAL

Children's Hospital of Philadelphia

Completed
89 enrolled 10 charts
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00812669 2025-07-08

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Cancer Trials Ireland

Phase 2 Completed
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡